Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey
Tóm tắt
Venous thromboembolism (VTE) confers considerable morbidity and mortality in hospitalized patients, although few studies have focused on the critically ill population. The objective of this study was to understand current approaches to the prevention and diagnosis of deep venous thrombosis (DVT) and pulmonary embolism (PE) among patients in the intensive care unit (ICU). Mailed self-administered survey of ICU Directors in Canadian university affiliated hospitals. Of 29 ICU Directors approached, 29 (100%) participated, representing 44 ICUs and 681 ICU beds across Canada. VTE prophylaxis is primarily determined by individual ICU clinicians (20/29, 69.0%) or with a hematology consultation for challenging patients (9/29, 31.0%). Decisions are usually made on a case-by-case basis (18/29, 62.1%) rather than by preprinted orders (5/29, 17.2%), institutional policies (6/29, 20.7%) or formal practice guidelines (2/29, 6.9%). Unfractionated heparin is the predominant VTE prophylactic strategy (29/29, 100.0%) whereas low molecular weight heparin is used less often, primarily for trauma and orthopedic patients. Use of pneumatic compression devices and thromboembolic stockings is variable. Systematic screening for DVT with lower limb ultrasound once or twice weekly was reported by some ICU Directors (7/29, 24.1%) for specific populations. Ultrasound is the most common diagnostic test for DVT; the reference standard of venography is rarely used. Spiral computed tomography chest scans and ventilation–perfusion scans are used more often than pulmonary angiograms for the diagnosis of PE. ICU Directors recommend further studies in the critically ill population to determine the test properties and risk:benefit ratio of VTE investigations, and the most cost-effective methods of prophylaxis in medical–surgical ICU patients. Unfractionated subcutaneous heparin is the predominant VTE prophylaxis strategy for critically ill patients, although low molecular weight heparin is prescribed for trauma and orthopedic patients. DVT is most often diagnosed by lower limb ultrasound; however, several different tests are used to diagnose PE. Fundamental research in critically ill patients is needed to help make practice evidence-based.
Tài liệu tham khảo
Stein PD, Henry JW: Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995, 108: 978-981.
Joynt GM, Kew J, Gomersall CD, Leung VYF, Liu EKH: Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest 2000, 117: 178-183. 10.1378/chest.117.1.178
Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts W: Prophylaxis of venous thromboembolism in the critically ill. Arch Intern Med 2001, 161: 1268-1279. 10.1001/archinte.161.10.1268
Neuhaus A, Bentz RR, Weg JG: Pulmonary embolism in respiratory failure. Chest 1978, 73: 460-465.
Moser KM, LeMoine JR, Nachtwey FJ, Spragg RG: Deep venous thrombosis and pulmonary embolism: Frequency in a respiratory intensive care unit. JAMA 1981, 246: 1422-1424. 10.1001/jama.246.13.1422
Saeger W, Genzkow M: Venous thromboses and pulmonary emboli in post-mortem series: Probable causes by correlations of clinical data and basic diseases. Pathol Res Pract 1994, 190: 394-399.
Schonhofer B, Kohler D: Prevalence of deep-venous thrombosis of the leg in patients with acute exacerbations of chronic obstructive pulmonary disease. Respiration 1998, 65: 173-177. 10.1159/000029254
Harris LM, Curl GR, Booth FV, Hassett JM Jr, Leney G, Ricotta JJ: Screening for asymptomatic deep vein thrombosis in surgical intensive care patients. J Vasc Surg 1997, 26: 764-769.
Hirsch DR, Ingenito EP, Goldhaber SZ: Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995, 274: 335-337. 10.1001/jama.274.4.335
Marik PE, Andrews L, Maini B: The incidence of deep venous thrombosis in ICU patients. Chest 1997, 111: 661-664.
Geerts WH, Code KI, Jay RM, Chen E, Szalai JP: A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994, 331: 1601-1606. 10.1056/NEJM199412153312401
Cade JF: High risk of the critically ill for venous thromboembolism. Crit Care Med 1982, 10: 448-450.
Fraisse F, Holzapfel L, Couland JM, Simonneau G, Bedock B, Feissel M, Herbecq P, Pordes R, Poussel JF, Roux L, and the Association of Non-University Affiliated Intensive Care Specialist Physicians of France: Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am Rev Resp Crit Care Med 2000, 161: 1109-1114.
Geerts WH, Jay RM, Code KI, Chen E, Szalai JP, Sibil EA, Hamilton PA: A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996, 335: 701-707. 10.1056/NEJM199609053351003
Griffith LE, Cook DJ, Guyatt GH, Charles C: Comparison of open versus closed questionnaire formats in obtaining demographic information from Canadian general internists. J Clin Epidemiol 1999, 52: 997-1005. 10.1016/S0895-4356(99)00106-7
Cook DJ, Guyatt Gh, Juniper E, Griffith L, McIlroy W, Willan A, Jaeschke R, Epstein R: Interviewer versus self-administered questionnaires in developing a disease-specific, health related quality of life instrument for asthma. J Clin Epidemiol 1993, 46: 529-534.
Asch DA, Jedrziewski MK, Christakis NA: Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997, 50: 1129-1136. 10.1016/S0895-4356(97)00126-1
Palmer AJ, Koppenhagen K, Kirchhof B, Weber U, Bergemann R: Efficacy and safety of low molecular weight heparin, unfrac-tionate heparin and warfarin for thromboembolism prophylaxis in orthopedic surgery: A meta-analysis of randomized clinical trials. Haemostasis 1997, 27: 75-84.
Nurmohamed MT, van Riel AM, Henkens CM, Koopman MM, Que GT, d'Azemar P, Buller HR, ten Cate JW, Hoek JA, van der Meer J, van der Heul C, Turpie AG, Haley S, Sicurella A, Gent M: Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Hemost 1996, 75: 233-238.
Ramos R, Salem BI, De Pawlikowski MP, Coordes C, Eisenberg S, Leidenfrost R: The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest 1996, 109: 82-85.
Rathburn SW, Raskob GE, Whitsett TL: Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: A systematic review. Ann Intern Med 2000, 132: 227-232.
Wells PS, Brill-Edwards P, Stevens P, Panju A, Patel A, Douketis J, Massicotte P, Hirsh J, Weitz JI, Kearon C, Ginsberg JS: A novel and rapid whole-blood assay for D dimer in patients with clinically suspected deep vein thrombosis. Circulation 1995, 91: 2184-2187.
Ginsberg JS, Wells PS, Kearon C, Anderson D, Crowther M, Weitz JI, Bormanis J, Brill-Edwards P, Turpie AG, MacKinnon B, Gent M, Hirsh J: Sensitivity and specificity of a rapid whole-blood assay for D dimer in the diagnosis of pulmonary embolism. Ann Intern Med 1998, 129: 1006-1011.
Quinn DA, Fogel RB, Smith CD, Laposata M, Thompson BT, Johnson SM, Waltman AC, Hales CA: D dimers in the diagnosis of pulmonary embolism. Am J Resp Crit Care Med 1999, 159: 1445-1449.
Boldt J, Papsdorf M, Rothe A, Kumle B, Piper S: Changes of the hemostatic network in critically ill patients – is there a difference between sepsis, trauma and neurosurgery? Crit Care Med 2000, 28: 445-450. 10.1097/00003246-200002000-00026
Dhainaut JF: Introduction to the Margaux Conference on Critical Illness: Activation of the coagulation system in critical illness. Crit Care Med 2000, 28: S1-S3. 10.1097/00003246-200009001-00001
Cook DJ, Richard JD, Reeve BK, Randall J, Wigg M, Dreyfuss D, Brochard L: Ventilator circuit and secretion management strategies: A Franco-Canadian survey. Crit Care Med 2000, 28: 3547-3554. 10.1097/00003246-200010000-00034
Brown G, Dodek P: An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit. Crit Care Med 1997, 25: 1534-1538. 10.1097/00003246-199709000-00021
Vella K, Goldfrad C, Rowan K, Bion J, Black N: Use of consensus development to establish national research priorities in critical care. BMJ 2000, 320: 976-980. 10.1136/bmj.320.7240.976
Carrington M, Lachs MS, Feinstein AR: Use of methodologic standards in diagnostic test research. JAMA 1995, 274: 645-651.
Heffner JE, Feinstein D, Barbieri C: Methodologic standards for diagnostic test research in pulmonary medicine. Chest 1998, 114: 877-885.
Bates SM, Ginsberg JS, Straus S, Rekers H, Sackett DL: Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism. Can Med Assoc J 2000, 163: 1016-1021.
NIH Consensus Conference Report: Prevention of venous thrombosis and pulmonary embolism. JAMA 1986, 256: 744-749.
Thromboembolic Risk Factors (THRIFT) Consensus Group: Risk and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992, 305: 567-574.
ACCP Consensus Committee on Pulmonary Embolism: Opinions regarding the diagnosis and management of venous throm-boembolic disease. Chest 1998, 113: 499-504.
Clagett GP, Anderson FA Jr, Geerts W, Heit JA, Knudson M, Lieberman JR, Merli GJ, Wheeler HB: Prevention of venous thromboembolism. Chest 1998, 114(suppl): 531S-560S.
American Thoracic Society Clinical Practice Guideline: The diagnostic approach to acute venous thromboembolism. Am Rev Resp Crit Care Med 1999, 160: 1043-1066.
Keane MG, Ingenito EP, Goldhaber SZ: Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest 1994, 106: 13-22.
Ryskamp RP, Trottier SJ: Utilization of venous thromboembolism prophylaxis in a medical–surgical ICU. Chest 1998, 113: 162-164.
Cook DJ, Attia J, Weaver B, McDonald E, Meade M, Crowther M: Venous thromboembolic disease: An observational study in medical–surgical ICU patients. J Crit Care 2000, 15: 127-132. 10.1053/jcrc.2000.19224
Lederle FA: Heparin prophylaxis for medical patients? Ann Intern Med 1998, 128: 768-770.
Goldhaber SZ: Venous thromboembolism in the intensive care unit: The last frontier for prophylaxis. Chest 1998, 113: 5-7.
Cook D, Heyland D, Marshall J: On the need for observational studies to design and interpret randomized trials in ICU patients: A case study in stress ulcer prophylaxis. Intensive Care Med 2001, 27: 347-354. 10.1007/s001340000828